They found that the CXCL12 and CCL21 ligands and their corresponding receptors, CXCR4 and CCR7, were highly and significantly expressed in tumor cells with lymph node metastases associated with shorter survival in this cohort [32]. The gene discussed is CCR7; the disease is neoplasm.